← Back to Clinical Trials
Recruiting Phase 4 NCT04828824
Premature Discontinuation of Contraceptive Implants
Trial Parameters
Condition Contraception Behavior
Sponsor University of Colorado, Denver
Study Type INTERVENTIONAL
Phase Phase 4
Enrollment 600
Sex FEMALE
Min Age 14 Years
Max Age 23 Years
Start Date 2021-06-18
Completion 2025-12-31
Interventions
Ethinyl Estradiol / Norgestimate Oral Tablet
Brief Summary
To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).
Eligibility Criteria
Inclusion Criteria: 1. You are between ages of 14 to 22.9 years. 2. Started etonogestrel implant for the first time and have never used the implant before. Exclusion Criteria: 1. There is any contraindication to estrogen containing birth control. 2. Desire of pregnancy in next 12 months. 3. Plans to move from the area in next 12 months and is not able to come to the clinic.
Related Trials
NCT04828824
Premature Discontinuation of Contraceptive Implants
View Trial →
NCT06852508
TwySHE - An Mhealth Peer-navigator Intervention to Increase PrEP and Contraceptive Use
View Trial →
NCT06608862
The Impact of Hormonal Contraceptive Use and Lifestyle Factors on Fracture Risk and Bone Quality in
View Trial →